Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001384243-25-000004

Director sold 20,129 shares at $41.51 ($835,555)

  • Director acquired 20,129 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Quart Barry D · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-15 Exercise or conversion : show line 1 in the form 10b5-1 +20,129 $10.36 $208,536 32,675 D
2025-12-15 Sale : show line 2 in the form 10b5-1 −20,129 $41.51 $835,555 12,546 D
Open-market sales · 20,129 sh · avg $41.51 · $835,555

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-15 Exercise or conversion : show line 3 in the form 10b5-1 Share Option −20,129 0 D
Loading xslF345X05/form4-12172025_091228.xml…